These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3830955)

  • 1. Cefoxitin and cefamandole levels in the human bile.
    Basoli A; Fiocca F; Chirletti P; Schietroma M; Pierini N; Caprioli A; Speranza V
    Ital J Surg Sci; 1985; 15(4):347-53. PubMed ID: 3830955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial fluid concentrations of cefoxitin, cephazolin and cefamandole.
    Landau Z; Rubinstein E; Halkin H
    J Antimicrob Chemother; 1980 Sep; 6(5):657-63. PubMed ID: 7410286
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic prophylaxis in vascular surgery: pharmacokinetic study of four commonly used cephalosporins.
    Fradet G; Brister S; Richards GK; Prentis J; Brown RA; Chiu RC; Mulder DS
    J Vasc Surg; 1986 Mar; 3(3):535-9. PubMed ID: 3512862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of bile duct infections. VIII. Studies on biliary excretion of cefamandole (author's transl)].
    Tanimura H; Takenaka M; Hikasa Y; Hashino H; Rai F; Kataoka S; Sato T
    Jpn J Antibiot; 1979 Oct; 32(10):1049-55. PubMed ID: 513287
    [No Abstract]   [Full Text] [Related]  

  • 5. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
    Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1985 Oct; 42(10):2211-4. PubMed ID: 3864367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin.
    Phillips LE; Martin RF; Luper WE; Rogers TE
    Antimicrob Agents Chemother; 1981 Apr; 19(4):567-70. PubMed ID: 7247379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefoxitin assay using HPLC and a study of its biliary excretion].
    Pierini N; Caprioli A; Fiocca F; Basoli A; Chirletti P; Panicucci M
    Boll Chim Farm; 1982 Aug; 121(8):387-401. PubMed ID: 7150446
    [No Abstract]   [Full Text] [Related]  

  • 8. Stability of cefamandole nafate and cefoxitin sodium solutions.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1981 Jun; 38(6):875-9. PubMed ID: 7246563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F2-isoprostane and 4-hydroxynonenal excretion in human bile of patients with biliary tract and pancreatic disorders.
    Leo MA; Aleynik SI; Siegel JH; Kasmin FE; Aleynik MK; Lieber CS
    Am J Gastroenterol; 1997 Nov; 92(11):2069-72. PubMed ID: 9362195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental and clinical study of the biliary excretion of cefamandole (author's transl)].
    Brogard JM; Pinget M; Arnaud JP; Dorner M; Adloff M; Lavillaureix J
    Pathol Biol (Paris); 1981 Jan; 29(1):25-30. PubMed ID: 7010273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid HPLC analysis of cefoxitin in plasma and urine.
    Charles BG; Ravenscroft PJ
    J Antimicrob Chemother; 1984 Mar; 13(3):291-4. PubMed ID: 6725179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefamandole bile levels in patients with hepatobiliary disease.
    Uwaydah M; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1087-9. PubMed ID: 7159070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin.
    Fraser DG
    Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.
    Levi JU; Martinez OV; Malinin TI; Zeppa R; Livingstone A; Hutson D; Calhoun P
    Antimicrob Agents Chemother; 1984 Dec; 26(6):944-6. PubMed ID: 6524908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical versus systemic cephalosporin administration in elective biliary operations.
    Freischlag J; McGrattan M; Busuttil RW
    Surgery; 1984 Oct; 96(4):686-93. PubMed ID: 6435272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary colic without evidence of gallstones: diagnosis, biliary lipid metabolism and treatment.
    Einarsson K; Angelin B; Kelter U; Nyberg B; Sonnenfeld T
    Acta Chir Scand Suppl; 1986; 530():31-4. PubMed ID: 3460288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of resistance determinants to cefamandole and cefoxitin in Enterobacter cloacae strains.
    Vuye A
    Microbios; 1983; 38(153-154):159-69. PubMed ID: 6606106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile compositional changes and cholesterol stone formation following orthotopic liver transplantation.
    Farouk M; Branum GD; Watters CR; Cucchiaro G; Helms M; McCann R; Bollinger R; Meyers WC
    Transplantation; 1991 Oct; 52(4):727-30. PubMed ID: 1926353
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective randomized controlled study of prophylaxis with cefamandole in high risk patients undergoing operations upon the biliary tract.
    Cáinzos M; Potel J; Puente JL
    Surg Gynecol Obstet; 1985 Jan; 160(1):27-32. PubMed ID: 3917304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic management of biliary leaks after laparoscopic cholecystectomy.
    Rustagi T; Aslanian HR
    J Clin Gastroenterol; 2014 Sep; 48(8):674-8. PubMed ID: 24296422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.